A miRNA-Driven Inference Model to Construct Potential Drug-Disease Associations for Drug Repositioning

Table 3

Prediction results of associated diseases for the drug fluoxetine.

Drug	Common miRNA(s)	Disease	P value	Evidence
Fluoxetine	hsa-miR-27b	Cardiomyopathy, hypertrophic	0.0325	CTD confirmed
Fluoxetine	hsa-miR-27b	Carcinoma, oral	0.0368	CTD confirmed
Fluoxetine	hsa-miR-27b	Osteoarthritis	0.0152	CTD confirmed
Fluoxetine	hsa-miR-27b	Oral lichen planus	0.00872
Fluoxetine	hsa-miR-27b	Cryptosporidium	0.00872
Fluoxetine	hsa-miR-27b	Dyslipidemia	0.00218